05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
he Federal Trade Commission (FTC) announced on January 28, 2020 that threshold limits under the Hart...
Read More >
New York has amended its Human Rights Law to expand protection from employment discrimination for vi...
Read More >
For June 22, 2019 1. When Sully talks, aviation safety regulators should listen. (FT) 2. Odebrecht ...
Read More >
It is the assessment of the legislators that the injury concept had become too narrow in practice, s...
Read More >
Join in-house legal counsel, business leaders, human resource executives and other professionals for...
Read More >
In the first episode of our “Tech-Tuned Workplace” series, Jennifer Betts and Ruthie Goodboe provi...
Read More >